Drug Comparison Suits May Drive Shift In Pharma Ads

Rising demand from Medicare and private insurers for head-to-head studies of pricey drugs is triggering courtroom brawls over how drugmakers use that research in marketing materials — fights that experts say...

Already a subscriber? Click here to view full article